Sharon Kochan


Mr. Sharon Kochan is on the board of Sol-Gel, MediWound Ltd., Meridian Bioscience Israel Ltd. and Monteray Bay Labs Ltd. Mr. Kochan has served as Executive Vice President & President international, for Perrigo Company Plc., a global, over‑the‑counter, consumer goods and specialty pharmaceutical company listed on the New York Stock Exchange, since 2012, and has been a member of the Perrigo Executive Committee since 2007. From March 2007 to July 2012, he served as Executive Vice President, General Manager of Prescription Pharmaceuticals for Perigo and from 2005 to 2007, he was Senior Vice President of Business Development and Strategy for Perrigo. Mr. Kochan was Vice President, Business Development of Agis Industries (1983) Ltd. from 2001 until Perrigo acquired Agis in 2005.

Mr. Kochan completed the Senior Management Program at the Technion Institute of Management in Haifa, Israel, received an MS in Operations Research & Management Science from Columbia University in New York City and received a BS in Industrial and Management Engineering from Tel‑Aviv University in Tel‑Aviv, Israel.

Scroll to Top